These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 7575218)

  • 1. Tau, ubiquitin, and alpha B-crystallin immunohistochemistry define the principal causes of degenerative frontotemporal dementia.
    Cooper PN; Jackson M; Lennox G; Lowe J; Mann DM
    Arch Neurol; 1995 Oct; 52(10):1011-5. PubMed ID: 7575218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Familial frontotemporal dementia with ubiquitin-positive, tau-negative inclusions.
    Kertesz A; Kawarai T; Rogaeva E; St George-Hyslop P; Poorkaj P; Bird TD; Munoz DG
    Neurology; 2000 Feb; 54(4):818-27. PubMed ID: 10690970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The new neuropathology of degenerative frontotemporal dementias.
    Jackson M; Lowe J
    Acta Neuropathol; 1996; 91(2):127-34. PubMed ID: 8787144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropathological discrepancy between Japanese Pick's disease without Pick bodies and frontal lobe degeneration type of frontotemporal dementia proposed by Lund and Manchester Group.
    Ikeda K
    Neuropathology; 2000 Mar; 20(1):76-82. PubMed ID: 10935442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tau protein expression in frontotemporal dementias.
    Adamec E; Chang HT; Stopa EG; Hedreen JC; Vonsattel JP
    Neurosci Lett; 2001 Nov; 315(1-2):21-4. PubMed ID: 11711205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The neuropathology and biochemistry of frontotemporal dementia.
    Munoz DG; Dickson DW; Bergeron C; Mackenzie IR; Delacourte A; Zhukareva V
    Ann Neurol; 2003; 54 Suppl 5():S24-8. PubMed ID: 12833365
    [No Abstract]   [Full Text] [Related]  

  • 7. Histopathological changes underlying frontotemporal lobar degeneration with clinicopathological correlation.
    Shi J; Shaw CL; Du Plessis D; Richardson AM; Bailey KL; Julien C; Stopford C; Thompson J; Varma A; Craufurd D; Tian J; Pickering-Brown S; Neary D; Snowden JS; Mann DM
    Acta Neuropathol; 2005 Nov; 110(5):501-12. PubMed ID: 16222525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of oxidative stress in frontotemporal dementia.
    Gerst JL; Siedlak SL; Nunomura A; Castellani R; Perry G; Smith MA
    Dement Geriatr Cogn Disord; 1999; 10 Suppl 1():85-7. PubMed ID: 10436348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biochemical and molecular characterization of neurofibrillary degeneration in frontotemporal dementias.
    Delacourte A
    Dement Geriatr Cogn Disord; 1999; 10 Suppl 1():75-9. PubMed ID: 10436346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Frontotemporal dementias].
    Jankowicz E; Drozdowski W; Halicka D
    Neurol Neurochir Pol; 2000; 34(3):553-64. PubMed ID: 10979548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ubiquitin-positive neuronal and tau 2-positive glial inclusions in frontotemporal dementia of motor neuron type.
    Forno LS; Langston JW; Herrick MK; Wilson JD; Murayama S
    Acta Neuropathol; 2002 Jun; 103(6):599-606. PubMed ID: 12012092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Classic Pick's disease type with ubiquitin-positive and tau-negative inclusions: case report.
    Brito-Marques PR; Mello RV; Montenegro L
    Arq Neuropsiquiatr; 2001 Mar; 59(1):128-33. PubMed ID: 11299448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ballooned neurons in several neurodegenerative diseases and stroke contain alpha B crystallin.
    Lowe J; Errington DR; Lennox G; Pike I; Spendlove I; Landon M; Mayer RJ
    Neuropathol Appl Neurobiol; 1992 Aug; 18(4):341-50. PubMed ID: 1528389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frontal lobe degeneration: novel ubiquitin-immunoreactive neurites within frontotemporal cortex.
    Tolnay M; Probst A
    Neuropathol Appl Neurobiol; 1995 Dec; 21(6):492-7. PubMed ID: 8745238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frontotemporal dementia: evidence for impairment of ascending serotoninergic but not noradrenergic innervation. Immunocytochemical and quantitative study using a graph method.
    Yang Y; Schmitt HP
    Acta Neuropathol; 2001 Mar; 101(3):256-70. PubMed ID: 11307626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A case of frontotemporal lobar degeneration with ubiquitin-positive intraneuronal inclusions.
    Leel-Ossy L; Révész T; Almási K; Szucs I; Szabó E
    Ideggyogy Sz; 2007 Jul; 60(7-8):330-5. PubMed ID: 17713114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tau mutations cause frontotemporal dementias.
    Goedert M; Crowther RA; Spillantini MG
    Neuron; 1998 Nov; 21(5):955-8. PubMed ID: 9856453
    [No Abstract]   [Full Text] [Related]  

  • 18. Frontotemporal lobar degeneration and ubiquitin immunohistochemistry.
    Josephs KA; Holton JL; Rossor MN; Godbolt AK; Ozawa T; Strand K; Khan N; Al-Sarraj S; Revesz T
    Neuropathol Appl Neurobiol; 2004 Aug; 30(4):369-73. PubMed ID: 15305982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropathological features of frontotemporal dementia and parkinsonism linked to chromosome 17q21-22 (FTDP-17): Duke Family 1684.
    Hulette CM; Pericak-Vance MA; Roses AD; Schmechel DE; Yamaoka LH; Gaskell PC; Welsh-Bohmer KA; Crowther RA; Spillantini MG
    J Neuropathol Exp Neurol; 1999 Aug; 58(8):859-66. PubMed ID: 10446810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tau mutations in frontotemporal dementia.
    Wilhelmsen KC; Clark LN; Miller BL; Geschwind DH
    Dement Geriatr Cogn Disord; 1999; 10 Suppl 1():88-92. PubMed ID: 10436349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.